KPV is a tripeptide composed of lysine, proline and valine, corresponding to the C-terminal three residues of alpha-melanocyte-stimulating hormone. It is supplied here as a lyophilised powder in a sealed vial.
This listing is for the compound as an analytical and research material. No application, effect or property in humans or animals is stated or implied.
Background
Alpha-melanocyte-stimulating hormone is a thirteen-residue peptide. KPV represents its final three residues, synthesised independently as a discrete tripeptide. Its short length gives it a considerably lower molecular weight than most compounds in this catalogue, which is reflected in its handling and solubility characteristics.
It is not a licensed medicine in the United Kingdom and holds no marketing authorisation. It is not a controlled substance under the Misuse of Drugs Act 1971.
For structural detail, published literature and citations, see the compound reference entry: /compounds/kpv-10mg/
There are no reviews yet.